Exact solutions and equi-dosing regimen regions for multi-dose pharmacokinetics models with transit compartments

Abstract

Compartmental models which yield linear ordinary differential equations (ODEs) provide common tools for pharmacokinetics (PK) analysis, with exact solutions for drug levels or concentrations readily obtainable for low-dimensional compartment models. Exact solutions enable valuable insights and further analysis of these systems. Transit compartment models are a popular semi-mechanistic approach for generalising simple PK models to allow for delayed kinetics, but computing exact solutions for multi-dosing inputs to transit compartment systems leading to different final compartments is nontrivial. Here, we find exact solutions for drug levels as functions of time throughout a linear transit compartment cascade followed by an absorption compartment and a central blood compartment, for the general case of n transit compartments and M equi-bolus doses to the first compartment. We further show the utility of exact solutions to PK ODE models in finding constraints on equi-dosing regimen parameters imposed by a prescribed therapeutic range. This leads to the construction of equi-dosing regimen regions (EDRRs), providing new, novel visualisations which summarise the safe and effective dosing parameter space. EDRRs are computed for classical and transit compartment models with two- and three-dimensional parameter spaces, and are proposed as useful graphical tools for informing drug dosing regimen design.

Deconvolution of plasma pharmacokinetics from dynamic heart imaging data obtained by SPECT/CT imaging

“…The copyright holder for this preprint this version posted November 18, 2022. ; https://doi.org/10.1101/2022.11.17.517003 doi: bioRxiv preprint in pharmacokinetic modeling and is generally used as a model input to simulate PK profiles of drugs following different dosing regimens or under various pathophysiological conditions (Zhang, Wang et al 2012, Hof andBridge 2021). In this study, a biexponential equation, which adequately describes the concentration-time data of both intact 125 I-insulin and 125 I-Aβ40 peptides, was used as the forcing function (Figure 3A, C).…”

Reduction of quantitative systems pharmacology models using artificial neural networks

“…En la Figura 6.29 se observan las superficies de respuesta de PTA para los dos indicadores. Las superficies tienen forma de pétalo con un comportamiento similar a las regiones de régimen de equidosificación descritas por Hof F y Bridge LJ [124]. Se hace evidente que al utilizar el objetivo PK/PD de AUC entre 400 − 600 mg • h/L se alcanza un PTA máximo de 0.65, mientras que al utilizar el objetivo PK/PD de C min entre 15 − 20 mg/L se alcanza un PTA máximo de 0.35.…”